letter complement cystic fibrosi lieberman report consider overlap quantit c3 level cf subject test control group control group howev compos subject bronchiectasi chronic bronchiti cf rule use proper control group lieberman either place parallel diseas control group would provid meaning interpret concern role complement cystic fibrosi agre tendenc c3 higher cf femal cf male although lieberman quick dispel notion c3a implic aetiolog cf overlook one facet initi studi still make hypothesi feasibl rais c3 level cf oblig heterozygot hann et al report serumc5 rais cf patient parent initi data c5 level radial immunodiffus haemolyt studi confirm find support hypothesi cf either complementcaus complementmedi disord c3alik molecul c3a bradykinin either alon complex igg give rise physiolog patholog state cf